Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer
- 15 November 2023
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 648, 123606
Abstract
No abstract availableKeywords
Funding Information
- University of Isfahan
This publication has 56 references indexed in Scilit:
- Chitosan‐Capped Mesoporous Silica Nanoparticles as pH‐Responsive Nanocarriers for Controlled Drug ReleaseChemistry – An Asian Journal, 2013
- Molecular‐targeted agents combination therapy for cancer: Developments and potentialsInternational Journal of Cancer, 2013
- Drug Resistance and the Role of Combination Chemotherapy in Improving Patient OutcomesInternational Journal of Breast Cancer, 2013
- Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)Breast Cancer Research and Treatment, 2012
- The role of HER2 in cancer therapy and targeted drug deliveryJournal of Controlled Release, 2010
- Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cellsJournal of Materials Chemistry, 2009
- Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells in VitroBiochemistry, 1997
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol DesignJNCI: Journal of the National Cancer Institute, 1994
- The bet method of analysis of gas adsorption data and its relevance to the calculation of surface areasSurface Technology, 1976
- A model for the packing of lipids in bilayer membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1975